Pharmaceutical Approval Update.

Pharmaceutical Approval Update. P T. 2019 Jul;44(7):405-435 Authors: Choy M Abstract Mavenclad (cladribine) tablets for relapsing MS forms; Duaklir Pressair (aclidinium bromide/formoterol fumarate) inhalant for COPD; Evenity (romosozumab-aqqg) injection for osteoporosis. PMID: 31258309 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31258309?dopt=Abstract

Source: P and T - July 2, 2019 Category: Drugs & Pharmacology Tags: P T Source Type: research

More News: Aclidinium Bromide | Chronic Obstructive Pulmonary | Drugs & Pharmacology | Orthopaedics | Osteoporosis